How can dermatologists effectively position lebrikizumab as a treatment option to patients with atopic dermatitis, considering the variety of other available therapies?
Featuring Mona Shahriari, MD |
Dermatologist, Yale University School of Medicine
Central CT Dermatology
Cromwell, CT
Related Media
Powered by Polaris TM